ShareJunction - Stock Forum Messages %%%:

Back

First < Newer 3121-3140 of 10899 Older> Last

Latest Forum Topics / Biosensors

Post Reply

Is Biosensors a good buy?

rogeryap
Member

16-Apr-2011 13:23

rogeryap About Contact Quote this Post!

x 0
x 0

Alert Admin

Sounds scary

Useful To Me Not Useful To Me

Laulan
Master

16-Apr-2011 12:54

Laulan About Contact Quote this Post!

x 0
x 0

Alert Admin

I won't be surprised that BIG has not made the $$$ expected by the market.

JustForFun ( Date: 16-Apr-2011 12:09) Posted:

results out last week of May for the last couple of years.....the 27/4 u mentioned was the notification of when the results will be released.

Useful To Me Not Useful To Me

JustForFun
Member

16-Apr-2011 12:09

JustForFun About Contact Quote this Post!

x 0
x 0

Alert Admin

results out last week of May for the last couple of years.....the 27/4 u mentioned was the notification of when the results will be released.

Useful To Me Not Useful To Me

swissvic
Member

16-Apr-2011 10:06

swissvic About Contact Quote this Post!

x 0
x 0

Alert Admin

result out in last year was mid of last week of april.

around 27/4,so in 10 day time ,we will know.

at meantime it will move higher .

Useful To Me Not Useful To Me

lostbell
Member

16-Apr-2011 07:06

lostbell About Contact Quote this Post! Style: Technical Mood:

Yells: "GOD BLESS EVERYONE!!!"

x 0
x 0

Alert Admin

Typically BIG full year results only May end week. They annonce the result date by end of April.

rogeryap ( Date: 15-Apr-2011 23:00) Posted:

Read from another forum Tat results are out next week, can anyone verify? Tks

Useful To Me Not Useful To Me

rogeryap
Member

15-Apr-2011 23:00

rogeryap About Contact Quote this Post!

x 0
x 0

Alert Admin

Read from another forum Tat results are out next week, can anyone verify? Tks

Useful To Me Not Useful To Me

rogeryap
Member

15-Apr-2011 16:54

rogeryap About Contact Quote this Post!

x 0
x 0

Alert Admin

looks like still got the firepower to move higher!!

Useful To Me Not Useful To Me

swissvic
Member

15-Apr-2011 16:53

swissvic About Contact Quote this Post!

x 0
x 0

Alert Admin

strong support at 1.33 ,so it should be good for run to 1.38 by mid next week

Useful To Me Not Useful To Me

james87
Veteran

15-Apr-2011 16:38

james87 About Contact Quote this Post!

x 0
x 1

Alert Admin

I also sold my holdings at 1.33. But if it goes down later...I'll really like to pick up again. It is stable with good potential.

Useful To Me Not Useful To Me

rogeryap
Member

15-Apr-2011 15:53

rogeryap About Contact Quote this Post!

x 0
x 0

Alert Admin

guess u r rite to take profits off the table..no one can predict the highest price unless u r INSIDE...

Useful To Me Not Useful To Me

metaphoricsymbol
Member

15-Apr-2011 15:33

metaphoricsymbol About Contact Quote this Post!

x 0
x 0

Alert Admin

Sold most of my holdings. With the rise from 1.10 to 1.34 today. It is time for a correction - will come back again when it corrected to between 1.25-1.27

Arguably a rising wedge is forming if we take the peak on March 9 as part of the upper resistance line. Rising wedges are one of a sure sign of reversals. Good luck folks.

Useful To Me Not Useful To Me

metaphoricsymbol
Member

15-Apr-2011 15:02

metaphoricsymbol About Contact Quote this Post!

x 0
x 0

Alert Admin

Are we in an ascending triangle forming?

Useful To Me Not Useful To Me

infancybird
Senior

14-Apr-2011 20:46

infancybird About Contact Quote this Post!

x 0
x 0

Alert Admin

Good observation ``Investor`. I still cannot fathom out the reason for their(FDL) recent sales and the quick repurchase??. May be they know something good coming that we don`t know. You described the recent uptrend as slight but I see as quite ``explosive`` which is probably intiated by the Nobori stent approval in Japan and the recent recruitment of the new talented CFO. Most of the members of the senior management of BIG are now Asian and such move indicate that BIG are switching their focus into China now. Great transformation is coming , I believe.

investor ( Date: 14-Apr-2011 16:52) Posted:

A lot of people may not have noticed this. When Fidelity sold their shares on 30th Mar, the number of shares that they hold after the sale was 54.921 million.

In today's announcement, before the new purchase on 8th Apr, the number of shares that they own is 65.729 million. That is between 31st Mar to 7th Apr, they actually increase the number of shares by 10.808 million, without the need to report, as the total number of shares in Biosensors has increased, due to the new shares issued to the 2 new shareholders, and hence they have not breach the 5 % limit.

That could be the reason, why the shares have been on a slight uptrend recently.

Not a call to buy/sell.

Useful To Me Not Useful To Me

swissvic
Member

14-Apr-2011 17:13

swissvic About Contact Quote this Post!

x 0
x 0

Alert Admin

TODAY VOLUME AT 21,016,000 SHARE

18,000,000OF SHARE BUY IN AT 1.30.

AT THIS SUPPORT ,IT SHOULD BREAK 1.31 BY NEXT DAY EASY.

Useful To Me Not Useful To Me

metaphoricsymbol
Member

14-Apr-2011 16:59

metaphoricsymbol About Contact Quote this Post!

x 0
x 0

Alert Admin

1.30 will be hard to cross. May have to pull back before going higher.

Useful To Me Not Useful To Me

investor
Senior

14-Apr-2011 16:52

investor About Contact Quote this Post!

x 1
x 0

Alert Admin

Useful To Me Not Useful To Me

infancybird
Senior

14-Apr-2011 16:05

infancybird About Contact Quote this Post!

x 0
x 0

Alert Admin

Interesting...... they(FID) had just recently reduced their stake in BIG last month to just below 5% ( check company announcement in SGX March 2011) and now they may have realised it is a mistake to sell and decided to buy back again.

BIG potentially can go up to $1.50 soon as the new CFO has very good tract record in M& A and this augur well for BIG next strategic development.Sit tight for M& A and good news.

allright ( Date: 14-Apr-2011 15:27) Posted:

NOTICE OF A SUBSTANTIAL SHAREHOLDER'S INTEREST *

* Asterisks denote mandatory information

Name of Announcer *	BIOSENSORS INT'L GROUP, LTD.
Company Registration No.	EC 24983
Announcement submitted on behalf of	BIOSENSORS INT'L GROUP, LTD.
Announcement is submitted with respect to *	BIOSENSORS INT'L GROUP, LTD.
Announcement is submitted by *	YOH-CHIE LU
Designation *	CHAIRMAN
Date & Time of Broadcast	14-Apr-2011 12:34:26
Announcement No.	00027

> > ANNOUNCEMENT DETAILS

The details of the announcement start here ...

> > PART I

1. Date of notice to issuer * 14-04-2011

2. Name of Substantial Shareholder * (1) FMR LLC (2) FIL Limited and (3) Edward C. Johnson 3d

3.	Please tick one or more appropriate box(es): *
	Notice of a New Substantial Shareholder's interest. [Please complete Part II and IV]

> > PART II

1. Date of change of Deemed Interest 08-04-2011

2. Name of Registered Holder Please see below footnote

3. Circumstance(s) giving rise to the interest or change in interest Open Market Purchase

# Please specify details

The substantial shareholders are deemed to have an interest, by virtue of Section 7(4) of the Companies Act, Chapter 50 of Singapore, in shares acquired by the Registered Holders.

4. Information relating to shares held in the name of the Registered Holder

No. of Shares held before the change	65,729,000
As a percentage of issued share capital	4.92 %

No. of Shares which are subject of this notice	1,250,000
As a percentage of issued share capital	0.09 %

Amount of consideration (excluding brokerage and stamp duties) per share paid or received 1.23

No. of Shares held after the change	66,979,000
As a percentage of issued share capital	5.02 %

> > PART III

1. Date of change of [Select Option]

2. The change in the percentage level From % To %

3. Circumstance(s) giving rise to the interest or change in interest [Select Option]

# Please specify details

A statement of whether the change in the percentage level is the result of a transaction or a series of transactions:

> > PART IV

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	65,729,000
As a percentage of issued share capital	0 %	4.92 %
No. of shares held after the change	0	66,979,000
As a percentage of issued share capital	0 %	5.02 %

Footnotes

Name of Registered Holders are:
FID FDS - SOUTHEAST ASIA POOL
FID FDS - ASEAN POOL
FID FDS - PACIFIC POOL
FIDELITY SOUTH EAST ASIA FUND
FID FDS - SINGAPORE POOL
FID ASIA PACIFIC EX-JAP PLT 2
FA INT SOUTH EAST ASIA SUB
FID INFORMTN TECH CENTRAL FD
FID KOREA ASEAN EQ IT MTHR
SELECT TECHNOLOGY
FIJ IT JPN ASIA GROWTH MOTHER
VIP TECHNOLOGY PORTFOLIO
FA TECHNOLOGY FUND
FID PACIFIC BASIN FUND

In this notification, the percentage of shareholding is expressed based on 1,335,458,318 ordinary shares of the Company as at 14 April 2011.

Attachments

Total size = 0
(2048K size limit recommended)

Useful To Me Not Useful To Me

allright
Senior

14-Apr-2011 15:27

allright About Contact Quote this Post!

x 0
x 0

Alert Admin

NOTICE OF A SUBSTANTIAL SHAREHOLDER'S INTEREST *

* Asterisks denote mandatory information

Name of Announcer *	BIOSENSORS INT'L GROUP, LTD.
Company Registration No.	EC 24983
Announcement submitted on behalf of	BIOSENSORS INT'L GROUP, LTD.
Announcement is submitted with respect to *	BIOSENSORS INT'L GROUP, LTD.
Announcement is submitted by *	YOH-CHIE LU
Designation *	CHAIRMAN
Date & Time of Broadcast	14-Apr-2011 12:34:26
Announcement No.	00027

> > ANNOUNCEMENT DETAILS

The details of the announcement start here ...

> > PART I

1. Date of notice to issuer * 14-04-2011

2. Name of Substantial Shareholder * (1) FMR LLC (2) FIL Limited and (3) Edward C. Johnson 3d

3.	Please tick one or more appropriate box(es): *
	Notice of a New Substantial Shareholder's interest. [Please complete Part II and IV]

> > PART II

1. Date of change of Deemed Interest 08-04-2011

2. Name of Registered Holder Please see below footnote

3. Circumstance(s) giving rise to the interest or change in interest Open Market Purchase

# Please specify details

The substantial shareholders are deemed to have an interest, by virtue of Section 7(4) of the Companies Act, Chapter 50 of Singapore, in shares acquired by the Registered Holders.

4. Information relating to shares held in the name of the Registered Holder

No. of Shares held before the change	65,729,000
As a percentage of issued share capital	4.92 %

No. of Shares which are subject of this notice	1,250,000
As a percentage of issued share capital	0.09 %

Amount of consideration (excluding brokerage and stamp duties) per share paid or received 1.23

No. of Shares held after the change	66,979,000
As a percentage of issued share capital	5.02 %

> > PART III

1. Date of change of [Select Option]

2. The change in the percentage level From % To %

3. Circumstance(s) giving rise to the interest or change in interest [Select Option]

# Please specify details

A statement of whether the change in the percentage level is the result of a transaction or a series of transactions:

> > PART IV

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	65,729,000
As a percentage of issued share capital	0 %	4.92 %
No. of shares held after the change	0	66,979,000
As a percentage of issued share capital	0 %	5.02 %

Footnotes

Attachments

Total size = 0
(2048K size limit recommended)

Useful To Me Not Useful To Me

rogeryap
Member

14-Apr-2011 09:54

rogeryap About Contact Quote this Post!

x 0
x 0

Alert Admin

good news coming out???

Useful To Me Not Useful To Me

swissvic
Member

12-Apr-2011 17:53

swissvic About Contact Quote this Post!

x 0
x 0

Alert Admin

Nobori stent approved in Japan
Nobori stent approved for sale in Japan…
International Group (BIG) announced that Terumo Corporation
(Terumo) has received approval for the sale of its Nobori drugeluting
stent (DES) in Japan, based on a document released
by Japan's Ministry of Health, Labour and Welfare. The Nobori
DES uses the stent technology and proprietary Biolimus A9
drug licensed from BIG (similar to BIG's BioMatrix DES) in
exchange for royalty payments. Currently, BIG already enjoys
a stream of licensing and royalties revenue from Terumo for
its Nobori DES which is sold outside of Japan and U.S. We
note that Terumo had entered into a revised licensing agreement
with BIG in Apr 2008, whereby it agreed to pay BIG US$40m
in exchange for a reduction of the revenue sharing provisions
applicable to sales of the Nobori DES outside of Japan. This
suggests Terumo's optimism about the growth prospects of
the DES market as well as its ability to increase its penetration
rates, in our opinion.Biosensors
…means higher licensing revenue for BIG
has not announced or rolled out its plans for the launch of its
Nobori DES in Japan, we estimate that this should happen
sometime in the early part of FY12. Hence BIG would be able
to reap higher licensing revenues from Terumo when this
happens. The DES market for Japan is estimated to be worth
~US$600m and is currently dominated by the four U.S.
medical technology giants. We believe this is now likely to
change after Nobori's approval in Japan. Strong penetration in
the Japanese market would be underpinned by (i) the proven
safety and efficacy of BIG's DES technology and (ii) Terumo's
ability to leverage on Japanese physicians’ loyalty given that
it is the first local firm to rollout a DES.. While Terumo
Appointment of new CFO
hired Mr. Ronald Ede as its new CFO. Mr. Ede was formerly
the CFO of Mindray Medical International, the largest medical
equipment company in China which trades on NYSE. BIG
believes that Mr. Ede's expertise in the M& A area would be
invaluable in the group's future development as inorganic
growth is expected to play a key role in its expansion plans.. BIG also announced that it has
Reiterate BUY.
catalyst for growth following the approval of Nobori's sale in
Japan. We update our assumptions for BIG's licensing
revenues and bump up our FY12F revenue and core earnings
forecasts by 7.3% and 10.6% respectively. This in turn raises
our DCF-based fair value estimate from S$1.32 to S$1.48.

Reiterate
Biosensors International Group's Key Financial Data
EARNINGS FORECAST BALANCE SHEET
Year Ended 31 Mar (US$m) FY09 FY10 FY11F FY12F As at 31 Mar (US$m) FY09 FY10 FY11F FY12F
Revenue 119.0 116.2 157.9 229.7 Bank and cash balances 60.1 60.1 277.7 312.5
EBITDA 19.1 24.6 45.9 70.9 Other current assets 37.7 51.1 59.7 84.3
Depreciation and amortisation 2.9 2.7 2.8 2.7 Property, plant, and equipment 9.9 9.7 9.5 9.3
EBIT 16.2 22.0 43.2 68.2 Total assets 198.5 227.8 472.8 555.1
Net interests -2.8 -3.8 -5.0 -4.9 Debt 46.8 29.1 31.3 33.4
Share of results of JVs, net 7.3 14.9 19.0 23.1 Current liabilities excluding debt 45.4 51.0 53.3 57.5
Profit before tax 8.9 33.7 46.3 86.4 Total liabilities 94.6 83.1 87.5 93.8
Income tax expense -10.0 -1.6 -6.5 -10.4 Shareholders equity 103.9 144.7 385.3 461.3
Minority interests 0.0 0.0 0.0 0.0 Minority interests 0.0 0.0 0.0 0.0
Profit attributable to shareholders -1.1 32.1 39.8 76.0 Total equity and liabilities 198.5 227.8 472.8 555.1
CASH FLOW
Year Ended 31 Mar (US$m) FY09 FY10 FY11F FY12F KEY RATES & RATIOS FY09 FY10 FY11F FY12F
Op profit before working cap. chg. 29.0 34.9 35.0 70.9 EPS (US cents) -0.1 3.0 3.5 5.8
Working cap, taxes and int -18.0 -22.1 -17.8 -35.7 NTA per share (US cents) 8.7 12.3 28.1 33.9
Net cash from operations 11.0 12.8 17.2 35.2 EBIT margin (%) 13.6 18.9 27.3 29.7
Purchase of PP& E -5.1 -2.1 -2.5 -2.5 Net profit margin (%) -0.9 27.6 25.2 33.1
Other investing flows -0.4 0.0 0.0 0.0 PER (x) n.m. 3 2.8 2 8.7 17.0
Investing cash flow -5.5 -2.2 -2.5 -2.5 Price/NTA (x) 1 1.4 8.1 3 .5 2.9
Financing cash flow 0.3 -10.7 203.0 2.1 EV/EBITDA (x) 6 7.9 5 2.0 2 3.2 14.6
Net cash flow 5.8 0.0 217.7 34.7 Dividend yield (%) 0.0 0.0 0.0 0.0
Cash at beginning of year 54.3 60.1 60.1 277.7 ROE (%) -1.1 25.8 15.0 18.0

Cash at end of year 60.1 60.1 277.7 312.5 Net gearing (%) net cash net cash net cash net cashWe believe that BIG has obtained a newBUY

Useful To Me Not Useful To Me

First < Newer 3121-3140 of 10899 Older> Last

ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.